1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.

http://www.wikidata.org/entity/Q37398623

about

Magnetic resonance spectroscopy in Alzheimer's disease.Magnetic resonance spectroscopy in common dementias Contributions of magnetic resonance spectroscopy to understanding development: potential applications in the study of adolescent alcohol use and abuse Brain imaging of mild cognitive impairment and Alzheimer's disease.Prolonged rote learning produces delayed memory facilitation and metabolic changes in the hippocampus of the ageing human brain.1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Recent advances in magnetic resonance neurospectroscopy.Imaging genetics of structural brain connectivity and neural integrity markers.Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria.Effect of age and the APOE gene on metabolite concentrations in the posterior cingulate cortex.Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice.Reducing occupational stress with a B-vitamin focussed intervention: a randomized clinical trial: study protocol.Brain metabolic correlates of decision making in amnestic mild cognitive impairment.Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.Mild cognitive impairment: historical development and summary of research APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.1H magnetic resonance spectroscopy in dementia.Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus.Naming is associated with left temporal pole metabolite levels in neurodegenerative diseases.Socioeconomic, health, and psychosocial mediators of racial disparities in cognition in early, middle, and late adulthood.An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease.1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults.Cognitive impairment: classification by 1H magnetic resonance spectroscopy.Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by ¹H MRS in vitro.Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features.Executive function is associated with brain proton magnetic resonance spectroscopy in amnestic mild cognitive impairment.

P2860

Q30630699-507959FF-19B9-48F7-A891-331F3204AE0E Q30660402-A9420294-4CC4-4F4B-82E7-017F3610BC5D Q30775959-A2B81711-064E-4FF2-A956-AE2D65A2085B Q30849637-87401F63-FE26-4047-94A9-BDC18F304FEF Q30906513-E0C07DBF-2DB5-403A-97C4-90F81383F71F Q30945792-F34B20B4-BFF0-4634-8205-094C4611F331 Q30983010-9C70696E-93E3-44B8-9D9E-9A622F99A177 Q30989943-ABDED51B-EEAB-4BF2-AAE9-833E995549D1 Q30996805-563B92DB-BCC5-461F-838F-32D489176D10 Q31117145-8B11E953-961E-40B6-AF60-91D98881D72E Q33516442-81E712F2-698E-46C3-A20A-13EE1BFC2456 Q33624213-B32D108D-1F4A-4883-96BE-804D5D17CC0F Q33716031-9A262960-3307-4577-A087-1CA3F9C85237 Q33726019-64F0A2A3-1A3F-46B2-A5E3-91A0E3FE5D10 Q34029600-AA14CBFD-C9E6-41D7-8E09-80B73B7F3351 Q34247831-9009E71A-B2CE-49F7-98F8-4BDC201414EB Q34325302-B7BB99E4-7CF3-4C13-9A0C-316684CB11D4 Q34911854-FA03448A-280F-4698-89C5-FEBE433443FD Q35097548-A6D609DF-6B10-459B-8528-6DDFA3F3F40B Q35210272-35E0E377-7558-4C05-BDB5-A1299111D0E9 Q35236843-BBF782E1-2B2E-47B7-A963-A0AC677D6005 Q36083501-6C4DCEAD-EB26-403B-8845-093BBC88616C Q36209987-5730909A-F6A0-4280-A2AC-A84D31285660 Q36257224-29257F55-FAD7-4912-84D6-14EFD2FF51D2 Q37150637-94241D66-8FF5-4EBF-A4EF-D776552FED28 Q37398634-D434C8D6-928F-428C-8E3D-F4A2D9FAB7C3 Q37418999-CC557ABC-B03E-4A9C-80EE-F15A1E503CFE Q37459037-0C9F8D5C-AED2-4AA7-B803-08CFC24905DC Q37513659-C7E240BD-9836-4E70-9B72-78E867EBB05B Q38392737-49AC7A32-EC3C-4789-B566-E5010B609E81 Q38911468-3FBC05F6-1F13-4D5C-A7F9-7E51CCA70838 Q42103589-DFCB5677-26BD-4D88-ABB8-6B9B123245E4 Q42665050-5D406DA5-75A6-4FDC-B993-70915144FB3E Q44791946-70F6F123-0358-4826-9489-61455CDCFA33 Q46792185-B159BCF4-DBA2-4274-8E3B-86700662C05A Q48219698-CA2745AA-5029-4087-BEC1-54AD00A6681D Q48715143-7B638B33-D1C0-4EEF-9C1B-3A8E61FD51B6 Q51108602-1E89E443-1163-4454-98AF-237E477C3C93 Q51972858-9720D96A-8BFA-4FB6-9B41-D35E5FC87160

P2860

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.

http://www.wikidata.org/entity/Q37398623

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

1H magnetic resonance spectros ...... rment and Alzheimer's disease.

@en

1H magnetic resonance spectros ...... rment and Alzheimer's disease.

@nl

type

label

1H magnetic resonance spectros ...... rment and Alzheimer's disease.

@en

1H magnetic resonance spectros ...... rment and Alzheimer's disease.

@nl

prefLabel

1H magnetic resonance spectros ...... rment and Alzheimer's disease.

@en

1H magnetic resonance spectros ...... rment and Alzheimer's disease.

@nl

P1433

Q37398623-D6B165F7-9C93-4C74-B3E7-2CA2407E972E

P1476

Q37398623-F4D345A6-EA0E-4BF4-A31D-47C712F49D97

P2093

Q37398623-10DD4C15-8F61-418D-8E74-3F97103986D2

Q37398623-590CFADF-D619-4657-822C-C9B2692C8603

Q37398623-97C39D5E-F541-42C1-A072-4D3AC3051EB7

P2860

Q37398623-00A1BFD4-6091-4AFC-94E0-FF694840C1F8

Q37398623-0126570F-BD76-4375-8DA9-1F917D69C309

Q37398623-0494C45E-8E13-4F34-A8CF-F9AAD5358E4E

Q37398623-087B1C41-C92A-4985-8201-F7A8AC108FEE

Q37398623-12650DEF-7FFD-4919-860F-92E216781CEA

Q37398623-15926EBC-3DF4-4D66-90F0-C7A3C2F13F40

Q37398623-1851C2FC-D8D9-4FBD-8666-FF7C354401E2

Q37398623-19A6AF22-8330-45B1-958C-FB0FB0CB5614

Q37398623-1F799499-498A-44BF-A108-A6179D90E38B

Q37398623-25FE98FB-4E85-49D4-AE83-80248BFB949A

P304

Q37398623-5BF6B113-795B-4B87-9538-59EE768A6B58

P31

Q37398623-FEBCE5A2-6BE9-4841-AB10-D302A5F3F048

P356

Q37398623-13097228-EF48-4BD5-B19F-1122BA1D8EE2

P433

Q37398623-8AC89907-D24F-4BAE-944B-80C2AF5E014F

P478

Q37398623-E70BDB9B-DDED-4F0F-96EB-CC660F1B3A4C

P50

Q37398623-1768E78B-988D-43B4-88EF-9BE5D7664C57

Q37398623-1A420B90-E7B1-4A00-8E44-F9EA89804888

Q37398623-4DA6820F-03AE-489C-B0C2-86B3F996385F

Q37398623-741C9428-4BF4-4A3E-B0E1-4633DAA48B98

Q37398623-8947EA1B-5EF2-4B27-9913-E62C8C3240B3

P577

Q37398623-2859886A-908E-44DD-88F4-9FBA638CAD10

P5875

Q37398623-541AAB41-D8EC-4BC9-8B37-2E30E8F3FC95

P698

Q37398623-909AD97C-4E1C-4AD2-89F5-B23D54FF3647

P921

Q37398623-B118B95C-9D17-499B-A0BE-03A5B937B5FB

P932

Q37398623-F0E697CF-C91F-4F3F-917F-F141FB253109

P356

S1355617702870084

P1433

Journal of the International Neuropsychological Society

P1476

1H magnetic resonance spectros ...... rment and Alzheimer's disease.

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Eric G Tangalos

http://www.w3.org/2001/XMLSchema#string

Robert J Ivnik

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Mild cognitive impairment: clinical characterization and outcome

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Magnetic resonance spectroscopy in AD.

In vivo MR spectroscopy of human dementia.

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

P304

934-942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1355617702870084

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

David S Knopman

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11057934

http://www.w3.org/2001/XMLSchema#string

P698

12405545

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2766804

http://www.w3.org/2001/XMLSchema#string